Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23241,79,0.88 [0.53-1.45],0.6132934315338054
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23728,126,1.12 [0.82-1.54],0.464423565006143
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23519,867,0.98 [0.85-1.12],0.7574046789794703
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,261,0.89 [0.68-1.17],0.401682405370339
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23070,2337,0.99 [0.91-1.07],0.7985183600266325
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23292,1765,0.97 [0.88-1.07],0.535752046492098
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23574,844,0.98 [0.85-1.13],0.7860020757984281
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23682,37,1.02 [0.53-1.94],0.962792071942462
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22662,538,1.06 [0.90-1.25],0.4610807957481032
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21906,516,1.04 [0.88-1.23],0.614543873470363
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22122,148,0.83 [0.57-1.20],0.3213723088472857
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17617,1023,1.01 [0.90-1.15],0.8239494192942413
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21925,249,1.06 [0.83-1.34],0.6356602925117469
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23718,988,1.01 [0.89-1.15],0.8520119049798733
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,23801,317,0.88 [0.69-1.12],0.3023111694759269
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23180,528,1.05 [0.89-1.23],0.5957593240557286
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23751,589,1.04 [0.89-1.22],0.6020213823094427
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22858,128,1.10 [0.80-1.51],0.5582828136017446
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,0.56 [0.20-1.58],0.2754636347667311
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23681,519,1.08 [0.92-1.28],0.3259290547947475
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23709,64,1.18 [0.78-1.78],0.4357944565175462
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,152,1.13 [0.86-1.50],0.38047902483167
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23738,138,1.13 [0.84-1.52],0.4011309974636069
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22946,294,1.04 [0.83-1.30],0.7442387261780974
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22858,206,0.88 [0.65-1.19],0.4044440999889382
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22797,67,1.21 [0.81-1.79],0.3520147420212256
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23816,43,1.00 [0.55-1.83],0.9983519115645444
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23787,112,1.06 [0.75-1.51],0.7281496185069009
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,23712,37,0.66 [0.29-1.54],0.3391920766676529
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23718,43,1.34 [0.87-2.06],0.1803709679342517
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,23585,271,1.03 [0.81-1.30],0.8190733775982781
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23765,62,1.18 [0.77-1.80],0.4438375285181233
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,66,1.29 [0.89-1.87],0.1752389673113257
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10630,36,0.86 [0.39-1.88],0.7015128125562022
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23663,997,0.91 [0.80-1.05],0.1850941809185726
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of meninges,23831,44,1.23 [0.77-1.98],0.3882719141203755
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,46,0.64 [0.30-1.39],0.2595366954015237
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,79,0.82 [0.49-1.37],0.4398097924397746
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of ovary,13155,83,1.43 [1.08-1.89],0.0128543331606147
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23834,234,0.84 [0.63-1.14],0.264776706931658
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,181,0.98 [0.72-1.33],0.8918672351397113
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23775,45,0.66 [0.31-1.41],0.2824226619426503
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,154,0.79 [0.54-1.16],0.2236867973754026
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,23804,242,0.88 [0.66-1.17],0.3910751475261605
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23772,465,0.99 [0.82-1.19],0.9200079061482372
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,259,0.72 [0.52-0.98],0.0361725334125775
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Carcinoma in situ of breast,11293,74,1.16 [0.79-1.69],0.4529007893675997
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11332,84,1.03 [0.69-1.54],0.8943631170561276
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20582,31,0.83 [0.59-1.18],0.3050583063877204
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20584,33,0.99 [0.50-1.97],0.9778728447354492
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23803,93,1.04 [0.70-1.54],0.8468019689950564
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",23803,91,1.06 [0.72-1.56],0.7834791715327661
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Leiomyoma of uterus,12603,340,0.85 [0.68-1.08],0.1854490348578849
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,17659,147,1.15 [0.89-1.50],0.2843498941467648
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lymphoid leukaemia,20577,26,0.73 [0.27-1.93],0.5245619316805884
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20678,127,0.85 [0.57-1.26],0.4222364099811869
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20626,75,0.94 [0.58-1.52],0.7886125398128114
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11378,66,1.37 [1.00-1.87],0.0471554362597591
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20596,45,0.54 [0.24-1.24],0.1462117366951171
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20601,50,1.22 [0.77-1.91],0.3991487266693175
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20614,63,1.30 [0.89-1.91],0.1780780773066208
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11359,47,0.99 [0.56-1.72],0.9598309515790102
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20600,49,0.98 [0.56-1.72],0.954054509643666
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9580,341,0.70 [0.52-0.92],0.0122501394157041
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20635,84,1.34 [0.99-1.82],0.061236179922641
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20597,46,1.07 [0.62-1.86],0.7993627735495487
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20607,56,0.66 [0.33-1.31],0.2308761715681243
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,23642,190,0.71 [0.50-1.02],0.0642471688255969
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,23803,87,0.65 [0.38-1.14],0.1313712488076922
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanoma in situ,20559,37,0.65 [0.28-1.52],0.3229482554973985
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20604,53,0.80 [0.42-1.52],0.4872816043601232
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20651,100,0.70 [0.42-1.16],0.1631385807102899
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20649,98,1.43 [1.11-1.85],0.0057159764475677
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20607,56,0.91 [0.52-1.60],0.7432825630589228
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,23685,128,1.06 [0.76-1.47],0.7433947010165989
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21101,550,0.99 [0.83-1.17],0.8646412917025256
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21131,580,0.98 [0.83-1.16],0.8449938691915602
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23596,255,1.15 [0.93-1.43],0.1949047138080318
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22623,39,0.77 [0.36-1.64],0.4997265938477235
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,66,1.21 [0.81-1.81],0.3456542305197733
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23145,1905,1.10 [1.02-1.20],0.0171980314635794
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22853,19,0.92 [0.34-2.47],0.8642874667246794
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23540,28,0.83 [0.35-1.96],0.664627871472806
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,874,1.16 [1.03-1.30],0.0123024081321877
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,874,1.16 [1.03-1.30],0.0123024081321877
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22632,48,0.90 [0.49-1.66],0.7420088313718891
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23604,770,0.97 [0.84-1.13],0.714184635505488
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,88,1.35 [1.00-1.82],0.0472957508078104
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23388,47,1.20 [0.74-1.95],0.4673011365113179
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23379,38,1.09 [0.61-1.96],0.7741510119867492
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23677,165,1.20 [0.93-1.55],0.1690306600841807
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23772,60,0.85 [0.48-1.51],0.5822043714330809
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23654,142,1.20 [0.91-1.58],0.2041536409143918
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22892,58,0.88 [0.50-1.55],0.6574240388578033
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20448,176,1.06 [0.79-1.42],0.7007465100882467
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22166,104,1.08 [0.74-1.58],0.6814204535555473
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22184,122,0.94 [0.65-1.36],0.7280240008614973
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20303,31,1.57 [1.02-2.41],0.0403751588502796
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22126,64,1.02 [0.64-1.65],0.922128829680331
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21820,126,0.86 [0.58-1.27],0.4473262588102223
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23714,139,1.38 [1.09-1.75],0.007035230307089
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23620,45,0.80 [0.40-1.61],0.5393206421649671
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23607,32,1.07 [0.56-2.05],0.8419818391447684
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23488,1426,0.93 [0.84-1.04],0.2172608431877014
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21349,1386,0.94 [0.85-1.05],0.3112206607494313
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20311,39,1.31 [0.79-2.16],0.2984336744523641
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22422,50,0.87 [0.47-1.63],0.6731786459944982
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20432,160,1.00 [0.73-1.37],0.988530321381061
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20325,53,1.33 [0.87-2.03],0.1912341209185482
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22349,2077,0.98 [0.89-1.07],0.6314242319906966
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20378,106,1.21 [0.88-1.67],0.2486949547152201
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20609,337,1.13 [0.93-1.38],0.2099562090018014
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23760,226,0.89 [0.66-1.18],0.4145379214968375
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23626,92,1.12 [0.77-1.61],0.562197049096179
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20362,90,1.17 [0.81-1.69],0.4004559488023502
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20306,34,0.96 [0.48-1.94],0.9156947322634844
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23472,1100,1.11 [1.00-1.23],0.0603637379764107
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20381,109,1.20 [0.86-1.66],0.2780626856881527
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20400,128,1.06 [0.75-1.50],0.7435983687969465
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20614,342,1.02 [0.82-1.26],0.8915033737929929
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20328,56,1.21 [0.77-1.91],0.4054062421224034
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23620,86,1.02 [0.67-1.55],0.9266612119811664
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20532,260,1.07 [0.85-1.35],0.5822471588805245
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20540,268,0.92 [0.70-1.19],0.5061134621439058
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,48,0.98 [0.55-1.74],0.9407243672192104
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2966,1.02 [0.95-1.10],0.6158198036593481
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22395,23,0.57 [0.19-1.74],0.3239079372560376
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22424,52,1.49 [1.06-2.11],0.0231332292207912
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1674,0.97 [0.88-1.07],0.548941591251441
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23688,1670,0.97 [0.88-1.07],0.5898637715724107
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22403,31,0.91 [0.43-1.93],0.8130865818319987
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23562,1068,1.04 [0.92-1.17],0.5327547032953248
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21046,774,1.06 [0.92-1.21],0.4309073307945665
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23836,105,0.91 [0.60-1.39],0.6651842190591928
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23606,31,0.57 [0.21-1.53],0.2617504461215756
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22571,77,1.19 [0.82-1.74],0.3552501364342417
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,99,1.28 [0.95-1.73],0.1033853708153239
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20381,109,1.14 [0.83-1.57],0.4221222677924803
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22283,105,0.95 [0.63-1.43],0.7922236229797964
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1485,57,1.29 [0.82-2.01],0.26854735188629
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,166,0.97 [0.68-1.37],0.8497151664802449
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22213,35,1.37 [0.82-2.28],0.2302706564958445
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1457,29,1.01 [0.45-2.28],0.979358675171476
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23488,1310,1.00 [0.90-1.12],0.98030471738992
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23634,59,1.00 [0.60-1.69],0.9857942005640324
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21939,245,1.03 [0.81-1.30],0.8297400675947132
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20618,346,1.09 [0.90-1.33],0.3653818234182698
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23760,147,0.90 [0.63-1.29],0.5599368173320647
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23191,49,0.89 [0.47-1.69],0.727873233065528
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,22748,691,0.94 [0.80-1.11],0.4874990549549662
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23235,93,0.92 [0.58-1.44],0.702813332266917
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23169,27,1.46 [0.89-2.39],0.1338579818320816
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23236,94,1.15 [0.80-1.63],0.4526035230334541
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16926,787,0.94 [0.80-1.10],0.4209051405658323
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,AV-block,21700,158,1.04 [0.77-1.43],0.7829500878393849
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,225,0.75 [0.55-1.04],0.0873675793771816
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16231,92,0.97 [0.63-1.50],0.8869479529377949
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21656,114,0.55 [0.33-0.92],0.0239345279690363
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21614,72,0.67 [0.37-1.22],0.1941052501905543
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,1.18 [0.51-2.75],0.7023604031271987
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,22006,464,1.12 [0.95-1.32],0.1846024901077837
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23215,1166,1.02 [0.91-1.15],0.7484073349451748
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22143,5225,1.00 [0.95-1.06],0.919395925647494
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22836,154,0.99 [0.71-1.37],0.9473771933202184
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Endocarditis,21582,40,1.02 [0.55-1.92],0.9452205660525508
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,442,0.89 [0.72-1.09],0.2614707139895139
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,22635,4257,1.01 [0.95-1.07],0.8450630865999313
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22643,4265,1.00 [0.95-1.07],0.8889639995816598
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23692,48,1.11 [0.64-1.90],0.7176391780240984
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18457,79,0.91 [0.56-1.47],0.7017128640311381
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18417,39,1.27 [0.77-2.12],0.3483668186574342
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,23757,591,0.81 [0.67-0.98],0.0343254116985651
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23384,57,0.95 [0.55-1.63],0.8389392830496348
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23352,1295,1.02 [0.91-1.14],0.7688651719829093
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23649,270,0.87 [0.66-1.14],0.302276446589618
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21724,182,1.15 [0.89-1.49],0.2834587638894699
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23623,523,1.04 [0.88-1.23],0.6576554754689554
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22482,425,1.07 [0.89-1.29],0.4562978655895211
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,105,1.05 [0.72-1.53],0.7899782774677777
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,182,1.07 [0.80-1.41],0.6564846370945283
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22713,31,0.43 [0.15-1.24],0.1170490198793086
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,39,1.09 [0.61-1.94],0.7731240293369929
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21764,222,0.77 [0.55-1.06],0.1052299812138862
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23201,59,1.21 [0.79-1.85],0.3792131232518058
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23270,128,1.22 [0.93-1.62],0.1537013275622765
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21653,111,1.10 [0.78-1.55],0.5807318769099554
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22743,61,1.38 [0.97-1.95],0.0739931218426917
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22727,45,1.25 [0.79-1.98],0.3401695788462571
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23162,34,0.96 [0.46-1.99],0.917070364675374
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22760,78,0.95 [0.60-1.52],0.8334977750226784
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22054,512,0.96 [0.80-1.16],0.7035667834987636
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23206,40,0.94 [0.48-1.84],0.8617780367713335
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23444,302,1.05 [0.84-1.30],0.6700267958669035
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23454,137,0.79 [0.53-1.18],0.2566899095387958
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23333,205,0.96 [0.72-1.28],0.8005843439342835
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16345,206,0.94 [0.70-1.26],0.6735878805277652
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23302,181,1.04 [0.78-1.38],0.8078360044773742
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22897,215,0.96 [0.72-1.27],0.7801314193703242
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23603,286,0.97 [0.76-1.23],0.7791669447081646
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23806,282,1.02 [0.81-1.29],0.8444019123009237
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21687,145,1.24 [0.95-1.61],0.1170018267930698
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23451,134,0.84 [0.57-1.25],0.3891477037727016
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23225,97,1.00 [0.66-1.50],0.9886827199029268
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23643,316,0.91 [0.71-1.16],0.4310518533758811
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23621,348,0.92 [0.73-1.15],0.4567855883123347
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23365,50,0.87 [0.48-1.60],0.6591989778104197
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23190,49,1.04 [0.59-1.83],0.8860214464945977
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23494,115,1.15 [0.84-1.59],0.3837715797612793
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23257,157,0.75 [0.51-1.12],0.1572398138255619
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,22951,269,0.99 [0.77-1.26],0.9188923826156888
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23152,45,1.31 [0.84-2.03],0.2339208493888362
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23686,449,0.97 [0.80-1.18],0.7561898742880113
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23700,319,0.87 [0.68-1.11],0.2687943399027207
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21232,1225,1.06 [0.95-1.17],0.315984403685267
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3176,0.99 [0.92-1.06],0.7000688422776662
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23646,371,0.94 [0.75-1.16],0.5587913725704804
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21464,1457,0.94 [0.85-1.05],0.2960969324376101
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20084,77,1.03 [0.67-1.57],0.9038213925006388
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,23363,1328,0.99 [0.89-1.10],0.8028885389203381
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21528,1521,0.99 [0.90-1.09],0.7934937184771352
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Vascular dementia,23745,17,1.02 [0.38-2.74],0.9615011970102808
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,0.71 [0.38-1.33],0.2850529177935836
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Bell's palsy,22397,68,1.03 [0.64-1.65],0.897568569583068
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22748,419,0.98 [0.81-1.20],0.8690964242983004
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,23529,178,0.61 [0.41-0.90],0.0139655766051974
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23768,187,1.12 [0.86-1.45],0.4099312541704641
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,0.37 [0.10-1.34],0.1319302139860095
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,49,1.26 [0.81-1.96],0.3084518724413571
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23403,52,0.96 [0.55-1.71],0.902241098186934
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,22493,222,0.97 [0.74-1.27],0.8438334832339741
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23418,1147,0.96 [0.86-1.09],0.5595046601992812
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23816,167,1.16 [0.89-1.52],0.2633193153496278
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23398,1424,1.03 [0.93-1.15],0.5144911877051463
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23518,44,0.87 [0.45-1.68],0.6731300899878404
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,23717,136,1.11 [0.81-1.52],0.5042442879690648
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,23395,44,1.27 [0.80-2.02],0.3078284537682179
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23822,59,1.20 [0.78-1.83],0.4065271149011188
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,64,1.26 [0.86-1.85],0.2371045796365057
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22399,70,1.21 [0.82-1.78],0.3294872056646536
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Memory loss,23713,65,0.65 [0.34-1.24],0.1883907241483409
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,22632,361,0.77 [0.60-0.99],0.0397398801197092
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23767,327,0.70 [0.53-0.92],0.0109378423459867
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,17327,91,0.78 [0.47-1.29],0.3364530572660041
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23658,130,0.92 [0.64-1.33],0.6517668852846104
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23314,985,0.99 [0.87-1.12],0.8915593826286694
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,22578,2631,0.98 [0.90-1.06],0.5810138834161931
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23757,65,1.15 [0.75-1.77],0.5172711415511234
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,335,0.95 [0.76-1.19],0.654122586413723
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23784,203,0.98 [0.73-1.31],0.886352325981731
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19877,276,0.94 [0.74-1.21],0.6483266843675195
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23403,52,0.53 [0.25-1.15],0.1104967849700613
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,102,0.79 [0.50-1.26],0.3304800181972858
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23720,71,0.65 [0.35-1.21],0.1740666098095006
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22415,86,0.88 [0.54-1.42],0.5930258845176588
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,22327,56,0.89 [0.50-1.57],0.6804678534907616
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,23736,385,0.86 [0.68-1.07],0.1792955213858326
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,22774,503,1.04 [0.88-1.24],0.6445828932874111
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,23830,75,1.57 [1.18-2.07],0.0018238348060228
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23406,55,0.67 [0.34-1.32],0.2523830679331555
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,33,0.81 [0.36-1.80],0.6010878652031088
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,23635,442,1.06 [0.89-1.27],0.5065000025639093
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,32,1.14 [0.60-2.17],0.7001512277731998
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,115,0.93 [0.63-1.38],0.7153870707539995
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22356,27,1.22 [0.66-2.25],0.5232351223175677
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,0.71 [0.38-1.33],0.2827081334850349
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23733,16,1.06 [0.40-2.84],0.9052373356185122
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23418,34,0.95 [0.46-1.93],0.8826970963745134
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23528,185,1.05 [0.79-1.38],0.7418216783319899
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23772,168,0.93 [0.66-1.30],0.6645028579180274
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,33,0.95 [0.46-1.95],0.8836123811261745
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23222,66,0.94 [0.57-1.57],0.8244251898247879
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23760,29,0.48 [0.17-1.38],0.1725978497489571
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23677,58,1.07 [0.66-1.73],0.7790133890816969
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1460,32,0.92 [0.41-2.06],0.8367991134195107
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1725,68,1.13 [0.72-1.78],0.5846881294180839
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23459,75,1.09 [0.72-1.67],0.6738181140782223
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23738,540,0.93 [0.77-1.11],0.4240824744996494
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,414,1.09 [0.92-1.30],0.3223356649509438
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,120,1.20 [0.90-1.60],0.2269057220287496
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23762,419,0.97 [0.79-1.18],0.7466136650016543
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,50,0.88 [0.47-1.64],0.6809217618639445
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23696,353,0.95 [0.76-1.19],0.6619037799793441
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,188,1.17 [0.92-1.50],0.2030163859097629
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23789,116,0.54 [0.33-0.91],0.0207655921587024
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23171,15,1.74 [1.08-2.80],0.0219983874300129
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23182,26,0.40 [0.12-1.29],0.1253480050510783
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23186,30,1.01 [0.51-2.03],0.9698026785089264
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23803,331,1.11 [0.91-1.35],0.3086527780003711
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23552,80,0.98 [0.62-1.55],0.9266251868057842
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23364,21,0.91 [0.36-2.30],0.8366025811317814
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,60,1.01 [0.60-1.69],0.9833316628321612
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23749,130,1.23 [0.93-1.62],0.1444773006033809
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23489,146,0.67 [0.44-1.03],0.0673732243677028
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23739,66,0.47 [0.23-0.95],0.0348529456228377
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23687,215,1.10 [0.86-1.41],0.4504121131807218
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23482,98,1.22 [0.89-1.68],0.2250968472377915
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23224,926,0.89 [0.77-1.03],0.1153229333919345
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,108,1.24 [0.92-1.68],0.1639772683397981
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,97,0.92 [0.59-1.41],0.6898641717738172
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23384,228,1.14 [0.91-1.43],0.2629617610275965
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23655,36,0.89 [0.43-1.86],0.7642010242176935
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,34,0.96 [0.47-1.95],0.9090001901436962
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23192,36,1.04 [0.55-1.95],0.9083010795234492
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23256,100,1.21 [0.87-1.67],0.2639637863699595
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,57,1.10 [0.68-1.78],0.7046454439477071
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23391,48,1.00 [0.57-1.76],0.991894035142825
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23241,43,0.95 [0.51-1.80],0.8830537854585977
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23518,46,1.01 [0.57-1.80],0.968250741011386
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23553,81,0.97 [0.61-1.54],0.8891832609574397
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23231,75,1.21 [0.84-1.76],0.3121854827598068
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23302,104,0.99 [0.67-1.47],0.9562705692753568
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23227,29,0.90 [0.40-1.99],0.7872146462493544
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23018,720,1.04 [0.90-1.20],0.6192355622133505
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23200,44,0.82 [0.41-1.61],0.5616375600650789
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23652,268,1.08 [0.86-1.35],0.5159525818821378
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23415,31,1.20 [0.66-2.19],0.5579933966106668
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23494,110,1.10 [0.78-1.56],0.5878150735927861
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23667,58,1.20 [0.79-1.83],0.385153399903927
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23803,78,0.84 [0.50-1.40],0.4947067513620043
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23734,122,0.50 [0.30-0.83],0.007204149165232
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,0.75 [0.38-1.49],0.4078940743916686
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23660,51,0.80 [0.42-1.54],0.5055842251203305
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23761,460,0.89 [0.73-1.09],0.2666280538771484
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23590,289,0.83 [0.64-1.09],0.1863435783594873
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23384,83,0.97 [0.62-1.53],0.9121197097342268
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23367,66,1.02 [0.63-1.64],0.938488267753399
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23588,69,0.61 [0.32-1.14],0.1221638348517885
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,210,0.94 [0.71-1.25],0.6894686156891043
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23574,55,0.44 [0.20-0.97],0.0420817917110469
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza,22722,69,0.88 [0.52-1.49],0.6281799984292589
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22721,68,0.85 [0.50-1.47],0.5691760621311341
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17629,117,1.18 [0.86-1.61],0.3071991429255792
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23716,272,0.82 [0.62-1.08],0.1564043163269303
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18910,1527,1.01 [0.91-1.12],0.8411192843489723
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19013,1501,1.02 [0.92-1.12],0.7682418880959234
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23596,84,1.30 [0.95-1.77],0.1035014378622349
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22703,50,1.44 [1.01-2.05],0.044964661172595
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,21201,155,0.97 [0.71-1.34],0.8676634077120537
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21080,34,0.56 [0.22-1.43],0.2256006299606524
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23077,2031,1.01 [0.93-1.11],0.7442031484557615
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22559,58,1.14 [0.72-1.80],0.5872670355666872
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22644,143,1.12 [0.83-1.51],0.4621023356926363
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23752,615,1.08 [0.93-1.25],0.3314945118361877
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22622,121,1.23 [0.92-1.65],0.1601068133903291
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3671,1.04 [0.98-1.11],0.2099686193676322
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22839,338,1.13 [0.93-1.37],0.2216652504431685
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,23577,440,1.08 [0.91-1.28],0.4050007328466248
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Emphysema,21205,159,0.94 [0.70-1.26],0.6632014768407366
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22728,100,0.92 [0.60-1.41],0.7037032952527611
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23684,1031,1.13 [1.01-1.26],0.0281563411265012
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,120,0.82 [0.54-1.25],0.3565510969895287
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Later onset COPD,22583,175,1.08 [0.82-1.43],0.5859028611089094
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,132,0.95 [0.66-1.37],0.7797005998934485
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,22603,102,1.06 [0.73-1.54],0.7630128177140694
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23650,548,1.12 [0.96-1.30],0.1521557669154892
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23688,1083,1.06 [0.95-1.19],0.2929259335855047
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23276,775,1.01 [0.88-1.17],0.8582789087465115
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,22638,33,1.43 [0.91-2.26],0.1251758431916182
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23791,176,0.98 [0.73-1.33],0.9197450455241524
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23773,743,1.04 [0.91-1.20],0.5390626308900973
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,23122,517,1.05 [0.89-1.24],0.5907889030868803
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural plaque,22652,47,0.93 [0.49-1.76],0.8178520300253963
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23499,846,1.15 [1.02-1.30],0.0217782467928893
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,115,1.00 [0.68-1.45],0.9835245117752602
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumothorax,22660,55,1.05 [0.65-1.72],0.8314537389073726
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pollen allergy,23812,232,0.86 [0.64-1.15],0.2968053627580238
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,1.21 [0.70-2.08],0.4868458177942424
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17544,32,1.04 [0.54-2.02],0.8958091913848434
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23630,528,1.14 [0.98-1.32],0.0911728835273527
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22773,272,0.82 [0.62-1.08],0.1626652543256231
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,22819,166,0.94 [0.68-1.30],0.6946614930496495
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,143,0.98 [0.69-1.37],0.8915897271194188
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,82,1.04 [0.69-1.56],0.8534604148348455
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,56,1.16 [0.75-1.80],0.5045226937540985
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,23668,133,0.94 [0.66-1.35],0.7478330824633956
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute gastritis,19051,60,0.67 [0.35-1.28],0.2249273928703575
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22449,148,1.01 [0.73-1.40],0.9543271476767358
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,23460,58,1.04 [0.63-1.72],0.8743713902547771
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23169,73,1.04 [0.67-1.64],0.8484673263196422
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19298,307,1.15 [0.95-1.40],0.1448833970138543
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22350,49,0.82 [0.42-1.58],0.5489570365678176
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23491,49,0.82 [0.42-1.58],0.5478231245252522
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,22457,156,0.82 [0.56-1.19],0.2934842675180208
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,809,1.06 [0.93-1.21],0.3447106712598338
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,19206,215,1.02 [0.79-1.33],0.8673823998764212
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22339,38,0.92 [0.47-1.80],0.8140497722598724
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.88 [0.52-1.49],0.6303582072233036
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,22599,97,1.38 [1.04-1.82],0.0236536925940588
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,22487,48,0.98 [0.56-1.74],0.9554368182262176
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,179,1.11 [0.85-1.45],0.4395863685168156
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,23658,1004,1.02 [0.90-1.15],0.7270219585154947
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,22518,79,1.11 [0.74-1.66],0.6176249378872417
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23540,53,1.09 [0.66-1.81],0.7367230242780276
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22516,77,1.22 [0.85-1.76],0.276472913280712
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,23123,227,1.09 [0.86-1.39],0.4774647421487273
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22033,1550,0.97 [0.88-1.07],0.5643438993563747
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,171,0.92 [0.66-1.27],0.6028572374584897
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,23739,643,1.01 [0.86-1.18],0.921322768385612
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22320,3329,0.99 [0.93-1.06],0.8601265725677584
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23425,529,1.18 [1.02-1.36],0.0293673032746413
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23773,371,1.25 [1.07-1.47],0.0058312669016772
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23009,113,1.58 [1.29-1.94],1.1405255874854162e-05
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22874,60,0.99 [0.59-1.66],0.9703753088895728
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23599,1097,1.03 [0.92-1.16],0.6030757419219488
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,22879,107,0.89 [0.58-1.36],0.5799188932149297
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23397,1096,1.04 [0.93-1.17],0.4552283107316254
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20293,2116,0.97 [0.89-1.05],0.4436634501202735
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19121,130,0.88 [0.60-1.30],0.5304409441304532
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23780,101,0.86 [0.55-1.35],0.5214661166130231
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23725,73,0.80 [0.47-1.38],0.4274380815367498
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23186,90,0.86 [0.54-1.39],0.5486784127351998
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,153,1.11 [0.84-1.47],0.4802836264100651
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19435,444,0.91 [0.75-1.11],0.3626939418891992
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,249,0.93 [0.71-1.21],0.583179907456511
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20927,1936,0.98 [0.89-1.07],0.6455597123928261
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19354,363,0.90 [0.72-1.13],0.3737820772324964
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6918,0.99 [0.94-1.03],0.5392144090031576
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,23376,874,0.96 [0.84-1.11],0.6038043779470923
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22956,60,1.16 [0.75-1.80],0.50138703850427
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18958,1101,0.95 [0.84-1.08],0.4384763795916223
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23142,46,0.79 [0.39-1.60],0.5163892701061668
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,22826,2343,0.97 [0.89-1.05],0.4702266005954273
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,23734,68,0.82 [0.47-1.43],0.4826298567565407
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,18207,30,1.36 [0.84-2.19],0.2118421381510208
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,21074,591,0.94 [0.79-1.12],0.486155927870469
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20552,69,1.03 [0.64-1.65],0.9180287766643588
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18240,63,1.26 [0.87-1.82],0.2192182135071934
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22618,116,1.33 [1.02-1.74],0.0330443152621536
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18680,503,0.94 [0.79-1.13],0.5199696550901776
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23819,334,0.94 [0.75-1.19],0.6179836386178459
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23041,602,0.87 [0.73-1.04],0.1379542108612416
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23199,760,0.92 [0.79-1.07],0.2921595923393065
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19117,126,1.19 [0.89-1.58],0.2473173732787255
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,19415,424,0.94 [0.77-1.15],0.5685259997644898
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23806,116,0.92 [0.63-1.36],0.6929886648902757
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20526,43,0.88 [0.45-1.72],0.7012905867268034
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19309,1132,0.87 [0.76-0.99],0.0364085979316342
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22469,168,1.11 [0.84-1.46],0.4541327490789744
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22440,139,0.91 [0.64-1.31],0.6131786220242765
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19499,1322,0.94 [0.84-1.06],0.3074418719215792
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22407,4230,0.96 [0.90-1.02],0.1831860569109857
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22881,167,0.82 [0.57-1.17],0.2713675500170223
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,23611,515,0.98 [0.82-1.17],0.8165780615160776
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19459,468,1.18 [1.01-1.37],0.031419605965647
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22371,70,0.84 [0.49-1.43],0.519118370239219
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23728,326,1.28 [1.08-1.51],0.004087844153419
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,666,1.07 [0.93-1.23],0.3516485279647983
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23389,887,0.97 [0.85-1.11],0.6687448328365595
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23042,146,1.14 [0.85-1.52],0.3841756311720991
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19223,1046,1.02 [0.91-1.15],0.75312255927632
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20513,1522,0.99 [0.90-1.10],0.9085857805695888
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23167,71,0.82 [0.48-1.41],0.4739038359881716
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23100,661,0.91 [0.78-1.08],0.2822086621991464
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18380,203,1.22 [0.99-1.52],0.0675342791271055
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23711,86,1.01 [0.66-1.54],0.961614483523748
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18480,303,1.10 [0.90-1.34],0.3666135851522213
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22627,125,1.21 [0.90-1.61],0.2070605416492676
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23834,55,0.99 [0.58-1.69],0.964936675003786
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22910,117,0.92 [0.62-1.37],0.6942096099600575
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Toxic colitis,22460,21,1.59 [1.00-2.53],0.0508572035466406
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19156,165,0.96 [0.69-1.31],0.7773297528288013
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22568,129,1.02 [0.72-1.43],0.9172480222461554
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22550,111,1.14 [0.82-1.58],0.451890442498741
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,20717,234,1.06 [0.83-1.36],0.6490420019632942
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,93,1.13 [0.79-1.60],0.4994011793283233
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,20682,199,1.16 [0.92-1.48],0.2106250130691028
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Volvulus,18235,58,0.97 [0.58-1.62],0.9038112958264448
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23804,136,0.99 [0.70-1.39],0.9336339010515928
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23611,72,0.81 [0.47-1.39],0.4454643857541247
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22559,131,0.77 [0.51-1.16],0.2157391386871653
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23281,479,0.98 [0.81-1.18],0.8206490246895319
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22981,179,0.88 [0.63-1.22],0.4478586873551158
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22574,146,1.10 [0.81-1.48],0.5528888992768248
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23618,202,0.98 [0.74-1.30],0.8833374116555002
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23757,341,0.93 [0.74-1.17],0.5405249482090815
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23452,36,0.83 [0.39-1.77],0.6280833628639224
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22564,2216,0.94 [0.86-1.03],0.1850394823093259
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23440,369,0.75 [0.58-0.96],0.0228049720053088
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23328,257,0.56 [0.40-0.78],0.000693224883305
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23490,688,1.01 [0.87-1.17],0.9251529583250996
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,0.81 [0.39-1.66],0.5595113592133846
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22482,54,0.99 [0.58-1.68],0.9699225571186126
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23108,37,1.05 [0.56-1.95],0.8877901388962732
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23612,196,1.00 [0.75-1.32],0.974318225819932
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22683,255,0.98 [0.77-1.27],0.9014375900248556
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22462,34,0.59 [0.23-1.48],0.2574181619929384
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23773,62,1.00 [0.61-1.65],0.9975241519257204
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22919,117,1.18 [0.86-1.61],0.3067321419760327
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23673,134,0.95 [0.66-1.37],0.7939216818078653
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23440,24,0.81 [0.31-2.10],0.6696576399395182
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22474,46,0.74 [0.36-1.54],0.4223307453632682
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23391,963,0.99 [0.87-1.13],0.9271768004656792
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22713,285,1.00 [0.79-1.27],0.9827128571612463
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22465,37,0.73 [0.33-1.63],0.4405560087636886
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23772,233,0.95 [0.73-1.25],0.7205776917003175
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23471,55,0.96 [0.56-1.65],0.8829645103805401
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23730,191,0.99 [0.74-1.32],0.9492246943770928
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23817,149,0.98 [0.70-1.37],0.9069921095452262
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22538,110,0.75 [0.48-1.19],0.2245215345233986
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22596,168,0.84 [0.59-1.19],0.3148452965360132
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23812,144,1.00 [0.72-1.39],0.9963539464840768
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22542,114,1.33 [1.01-1.75],0.0410524593620824
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23815,104,0.78 [0.49-1.24],0.3012624915912701
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20890,117,0.57 [0.35-0.94],0.0283575166103548
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22234,4024,0.99 [0.93-1.05],0.6566472392477622
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21075,2865,1.01 [0.94-1.09],0.7547776557491765
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20858,85,1.05 [0.70-1.57],0.827282567409601
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21363,135,1.15 [0.86-1.54],0.3382116520195629
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21370,142,0.96 [0.68-1.34],0.7923251451181499
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23644,101,0.98 [0.66-1.46],0.9292475864506594
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21271,43,0.93 [0.49-1.75],0.8199817126270916
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18873,663,1.03 [0.89-1.20],0.6930331637063869
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23789,114,0.92 [0.62-1.37],0.6921867734745434
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21480,252,0.99 [0.77-1.26],0.9170271333242704
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20819,5392,0.96 [0.91-1.01],0.1326924703801395
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22635,92,1.04 [0.70-1.56],0.8401708853981238
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20875,102,0.81 [0.51-1.28],0.3576447345446379
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21310,537,0.92 [0.77-1.11],0.3786108759569053
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23057,1829,0.94 [0.86-1.04],0.2337777581968381
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20974,201,0.93 [0.69-1.25],0.6182521965768231
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21033,260,0.95 [0.74-1.22],0.6676814786714029
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20908,135,0.89 [0.61-1.29],0.5260560947992226
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23378,34,1.09 [0.60-2.01],0.7721070301120251
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19341,1131,0.98 [0.87-1.11],0.7689216427631298
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18550,340,0.89 [0.70-1.13],0.3475982615733365
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23795,330,0.93 [0.73-1.18],0.5505033793099599
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18277,67,1.08 [0.69-1.69],0.7463578616447029
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18513,303,1.03 [0.83-1.28],0.7935778688706956
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21061,288,0.99 [0.78-1.25],0.9066075998589648
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18869,659,1.00 [0.86-1.17],0.974854209641282
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21253,25,1.18 [0.62-2.27],0.6127301057211907
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21715,487,1.09 [0.92-1.28],0.3274551639164668
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21477,249,0.87 [0.66-1.15],0.3385975188108493
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18822,612,0.97 [0.82-1.14],0.698400488226367
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20843,70,0.90 [0.54-1.50],0.6941040212096672
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20826,53,1.25 [0.82-1.90],0.3039428180826697
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22593,50,1.15 [0.71-1.88],0.5709103869247389
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23551,1008,1.07 [0.96-1.20],0.2232928134670432
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23117,574,1.12 [0.97-1.29],0.1174300041051352
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23737,301,1.03 [0.83-1.29],0.7646629030667341
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19764,1554,1.01 [0.92-1.12],0.8261442051027147
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18273,63,0.87 [0.50-1.51],0.624160168965415
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20841,68,1.00 [0.62-1.60],0.9951802345638586
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18235,25,1.08 [0.52-2.25],0.8315293724941809
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18307,97,1.08 [0.74-1.56],0.6949491036605042
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22745,202,0.96 [0.72-1.27],0.7610365666781994
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22754,211,1.04 [0.81-1.35],0.7476388673254449
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23807,74,1.15 [0.77-1.72],0.4956889887063845
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22590,1362,0.95 [0.85-1.06],0.3825320462799716
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20880,107,1.20 [0.88-1.63],0.2499637520332094
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18319,109,0.96 [0.66-1.41],0.8483033251160228
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21783,555,0.95 [0.80-1.13],0.5638809849018211
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19989,1779,1.00 [0.92-1.10],0.9279592080228778
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23396,52,1.24 [0.81-1.91],0.327620032614052
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23819,69,1.04 [0.66-1.64],0.874574858476694
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20843,70,0.95 [0.58-1.55],0.8305725492201919
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21737,964,0.98 [0.86-1.12],0.7724251148260549
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20832,59,0.76 [0.41-1.41],0.3844868929161402
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19177,967,1.00 [0.88-1.13],0.975276773646806
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22635,92,0.82 [0.51-1.32],0.417875559158481
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20832,59,0.86 [0.49-1.52],0.6020164096398648
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21331,103,0.96 [0.64-1.43],0.8286188506559452
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21117,344,1.06 [0.86-1.29],0.6010922804492498
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23534,190,1.03 [0.79-1.36],0.8147255314365333
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21639,411,0.94 [0.76-1.15],0.5249981870422837
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23746,286,1.05 [0.84-1.31],0.6650401959334978
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.25 [0.72-2.15],0.4272949754324998
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20954,181,1.08 [0.83-1.42],0.5666601107391744
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19108,532,1.00 [0.84-1.18],0.979556212059192
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21205,432,1.04 [0.87-1.25],0.6669358100780872
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20922,149,0.93 [0.66-1.32],0.6885383183123261
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18243,33,0.86 [0.40-1.84],0.701498721754803
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19743,1533,0.98 [0.89-1.09],0.7584818356380497
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18602,392,0.87 [0.69-1.08],0.2087579091893144
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23421,77,0.85 [0.51-1.42],0.5296876292316118
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23776,43,1.23 [0.75-2.01],0.4126106427207182
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22448,24,1.09 [0.52-2.31],0.8195869225223438
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18281,71,1.03 [0.66-1.60],0.8996225194680002
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21306,78,0.85 [0.51-1.40],0.5251392015378655
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18514,304,1.02 [0.82-1.27],0.852157595487066
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21010,237,0.95 [0.73-1.24],0.705148852587728
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21414,186,0.94 [0.70-1.27],0.7016795194608498
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21321,93,1.01 [0.69-1.49],0.9570401921618796
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20152,41,1.02 [0.57-1.84],0.94679505997968
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.38 [0.88-2.18],0.1642700459365675
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21297,524,0.93 [0.77-1.12],0.4304844163686164
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23422,78,1.25 [0.90-1.75],0.1853333805125454
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22900,2127,0.96 [0.87-1.04],0.3147763897625543
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20874,101,0.99 [0.66-1.46],0.945300143045755
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21544,316,0.83 [0.65-1.07],0.1595571295690342
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22613,167,1.03 [0.76-1.39],0.8529565657725227
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21359,131,0.96 [0.68-1.36],0.8118629086840267
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22165,937,0.93 [0.81-1.07],0.315646426613229
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21841,613,0.96 [0.82-1.13],0.6425251068488167
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20812,39,0.92 [0.47-1.78],0.804782511250026
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23478,134,1.44 [1.16-1.79],0.0008621947009819
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20907,134,0.81 [0.54-1.20],0.2879545294777788
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20826,53,1.20 [0.78-1.85],0.4101814370941699
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18243,33,0.65 [0.26-1.61],0.3483539221867026
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,726,0.95 [0.81-1.11],0.4860071350625738
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9660,63,0.86 [0.51-1.46],0.569537486562488
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12877,70,0.99 [0.62-1.58],0.9616236856641234
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23581,268,1.00 [0.78-1.28],0.9890865479554196
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23369,56,0.83 [0.44-1.54],0.5462708333097279
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23216,550,0.99 [0.84-1.18],0.9466505961315
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23690,18,0.51 [0.14-1.92],0.3228154406930368
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23698,157,1.11 [0.83-1.49],0.4660658359851264
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,21891,135,1.03 [0.74-1.43],0.8803723845079792
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,22707,41,1.29 [0.81-2.06],0.2851272827909249
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10304,982,0.90 [0.78-1.04],0.1405792293811724
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12980,173,0.94 [0.69-1.27],0.6744899763302087
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9712,115,0.91 [0.62-1.32],0.6140333330601646
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9927,330,0.97 [0.78-1.20],0.7823724012540934
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,376,1.01 [0.83-1.23],0.9510410415392716
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20064,3663,0.93 [0.87-1.00],0.0507773482541694
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23726,54,1.17 [0.73-1.86],0.512435908859228
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9394,72,0.51 [0.26-1.01],0.0549168963723284
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22592,191,0.93 [0.68-1.26],0.6375108402316891
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9975,653,0.88 [0.74-1.05],0.1678012480855686
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12864,206,1.09 [0.85-1.39],0.501245943320494
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9413,91,0.69 [0.40-1.18],0.1742795616959514
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12874,106,0.82 [0.53-1.26],0.3670085621478998
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9856,259,1.06 [0.85-1.32],0.6074834516931673
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,1.27 [0.85-1.90],0.2458527108240017
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10806,1209,0.91 [0.81-1.02],0.1114485630598563
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9369,47,0.55 [0.24-1.26],0.1576633805370727
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9680,83,0.59 [0.33-1.05],0.0735925033063736
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,35,1.32 [0.80-2.17],0.2856864609743996
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,39,0.89 [0.45-1.79],0.7472765046933455
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23082,1326,0.94 [0.83-1.05],0.2517377008031539
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22176,420,0.87 [0.70-1.08],0.1943528679842334
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12860,53,0.99 [0.58-1.69],0.9699178053743908
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23800,259,1.11 [0.89-1.39],0.3684006191169613
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9458,136,0.77 [0.51-1.18],0.23368551895469
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9427,105,1.16 [0.82-1.64],0.398989057964994
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9387,65,1.08 [0.66-1.74],0.7667655294333434
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23812,49,1.13 [0.68-1.86],0.6461021047444679
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22727,971,0.88 [0.76-1.01],0.0647860058660675
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12763,105,0.93 [0.63-1.38],0.7295756149607179
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9668,71,1.21 [0.84-1.74],0.2948717869619592
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9795,198,0.60 [0.41-0.87],0.0075629744107894
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9648,51,1.14 [0.71-1.82],0.5953835658538079
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9686,89,0.69 [0.41-1.17],0.1674224753383068
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22622,221,0.94 [0.71-1.25],0.6882290596034253
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23629,88,1.09 [0.74-1.62],0.6627188065253107
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9752,155,1.08 [0.81-1.43],0.6102618705331211
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9666,69,0.98 [0.61-1.56],0.923594227767352
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9953,356,0.79 [0.62-1.00],0.0527945011037994
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9652,55,0.60 [0.29-1.21],0.1521473820321563
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9915,318,0.95 [0.77-1.19],0.678641253070353
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23714,42,0.91 [0.47-1.77],0.7746249054996281
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9418,96,1.11 [0.77-1.61],0.566200635184162
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1286,0.96 [0.85-1.08],0.4709357414217322
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22521,120,1.11 [0.80-1.52],0.5336931046583253
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22720,54,0.92 [0.52-1.64],0.7827889437378244
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23374,61,0.54 [0.27-1.11],0.0935728635512439
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21905,149,1.02 [0.74-1.41],0.8983356394559523
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23639,326,0.95 [0.75-1.19],0.6351013189593518
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9681,84,0.94 [0.61-1.45],0.7928836625322098
